{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/croup/","result":{"data":{"firstChapter":{"id":"147ea703-8a02-5151-abf9-289eb232d7f7","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field af6b4d92-1609-478f-83a0-7f319a3a0c20 --><h1>Croup: Summary</h1><!-- end field af6b4d92-1609-478f-83a0-7f319a3a0c20 -->","htmlStringContent":"<!-- begin item 8e1ca933-a980-4a0c-a655-8b6c8de28fae --><!-- begin field e5b52536-6285-4e6b-b554-6c15ae932121 --><ul><li>Croup (laryngotracheobronchitis) is a common childhood disease that is usually caused by a virus. It is characterized by the sudden onset of a seal-like barking cough usually accompanied by stridor (predominantly inspiratory), hoarse voice, and respiratory distress due to upper-airway obstruction. Symptoms are usually worse at night. There may be a fever.</li><li>There is often a preceding 12–48 hour history of a non-specific cough, rhinorrhoea, and fever.</li><li>Croup most commonly affects children between 6 months and 6 years of age, with a peak incidence during the second year of life.</li><li>Mild croup symptoms include seal-like barking cough but no stridor or sternal/intercostal recession at rest.</li><li>Moderate croup symptoms include seal-like barking cough with stridor and sternal recession at rest; no agitation or lethargy.</li><li>Severe croup symptoms include seal-like barking cough with stridor and sternal/intercostal recession associated with agitation or lethargy.</li><li>Symptoms of impending respiratory failure include increasing upper airway obstruction, sternal/intercostal recession, asynchronous chest wall and abdominal movement, fatigue, pallor or cyanosis, decreased level of consciousness. The degree of chest wall recession may diminish with the onset of respiratory failure as the child tires.</li><li>A child should be immediately admitted when presenting with moderate or severe croup, or impending respiratory failure.</li><li>All children with mild, moderate, or severe croup should receive a single dose of oral dexamethasone (0.15 mg per kg body weight). If the child is too unwell to receive medication, inhaled budesonide (2 mg nebulised as a single dose) or intramuscular dexamethasome (0.6 mg/kg as a single dose) are possible alternatives.</li><li>Mild croup can usually be managed at home. However, reasons for admission include: chronic lung disease, congenital heart disease, neuromuscular disorders, immunodeficiency, age under three months, inadequate fluid intake, factors that might affect a carer's ability to look after a child with croup, and longer distance to healthcare, in case of deterioration. </li><li>Croup is usually self-limiting and symptoms usually resolve within 48 hours. If the child is being managed at home, the use of paracetamol or ibuprofen to control fever and pain should be advised, and parents should be advised to seek urgent medical advice if there is any deterioration.</li></ul><!-- end field e5b52536-6285-4e6b-b554-6c15ae932121 --><!-- end item 8e1ca933-a980-4a0c-a655-8b6c8de28fae -->","topic":{"id":"ce03d247-afbe-5290-832f-8f95361dd16e","topicId":"663c3878-b65e-49df-b738-7711612b31ed","topicName":"Croup","slug":"croup","aliases":[],"chapters":[{"id":"147ea703-8a02-5151-abf9-289eb232d7f7","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"b4d7d104-fefd-5285-8bf6-a20db31a3a6c","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"9b0196f5-c62f-557e-8c0b-8d5cdc4726b8","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"770a8563-687d-5b41-9629-8cdcd49a750a","slug":"changes","fullItemName":"Changes"},{"id":"10a53caf-873e-57a4-880d-aefdd5a5fb65","slug":"update","fullItemName":"Update"}]},{"id":"bf5dbb8f-554f-56b2-b8ce-62573dd2d938","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"7d9ae47b-5ea9-557f-b53a-5bb9f9b69fcb","slug":"goals","fullItemName":"Goals"},{"id":"a5f272bf-bd65-5548-a253-2eece07472f4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b1168d32-0a16-5a45-844c-2f9e792cfccc","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"41533497-a783-5f26-98e4-554a82823d80","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"34edf552-026f-5c4d-b4ae-95034786ca88","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ba739830-6b73-555a-9c5f-3bf3e5ec3743","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0b7a2081-6723-53ae-9566-0481028ad175","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"467402a7-bf22-5f5b-8ad9-090c0b1b6be5","slug":"definition","fullItemName":"Definition"},{"id":"93d4df12-d240-53a9-bbc6-ad12f8363460","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0128d0fb-1a94-57dd-b210-2b011720efa2","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"0fa5d183-650e-5e12-a927-5e0bcff458bd","slug":"prognosis-complications","fullItemName":"Prognosis and complications"}]},{"id":"90baebc8-47bc-5144-a5ac-07ace34fe1d7","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"b1189f4d-058a-54f6-83c8-43ed93b0d1ab","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"6c26580b-53cc-5db0-838c-71e5841fe898","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"efe34746-d360-5ce2-bdc6-4aab25a98130","slug":"management","fullItemName":"Management","subChapters":[{"id":"3020718f-b53d-5af1-89e6-5a92a4c59075","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"86c15ba0-c5cc-5a85-8d4c-490305d1540f","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"76c755b1-a126-5291-8ae0-44276cfd3747","slug":"corticosteroids","fullItemName":"Corticosteroids"},{"id":"742b7beb-da22-597a-9bf5-35f9a3b8ff50","slug":"paracetamol-ibuprofen","fullItemName":"Paracetamol and ibuprofen"}]},{"id":"7ea6cbf9-fc01-56dd-8c9d-9b9cc1a69282","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"c93aeb25-1189-5e59-bec3-5210121ed220","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"f0d23dbb-0a01-5d60-9e6f-17bbf65083b3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"be9ee413-fa04-55ba-88df-d9606ca98a64","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d2337c68-6aec-522d-a1c5-329947299478","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"982ad0fa-2b63-5ea4-b6a3-200dca208aaa","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"86f92b32-a806-57d4-a00e-be2a234bfdee","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7b0c8a60-9bbe-5830-8e82-d9e6b1567c0b","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"ce03d247-afbe-5290-832f-8f95361dd16e","topicId":"663c3878-b65e-49df-b738-7711612b31ed","topicName":"Croup","slug":"croup","aliases":[],"topicSummary":"Croup (laryngotracheobronchitis) is a common childhood disease that is usually caused by a virus.","lastRevised":"Last revised in February 2019","nextPlannedReviewBy":"2022-05-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2022-04","nextPlannedReviewByDisplay":"April 2022","specialities":[{"id":"e9e3ea2b-52b8-5242-bc9d-24052ea8647a","name":"Child health","slug":"child-health"},{"id":"bb606678-e2cc-550b-bd11-bd7b8e7d05e1","name":"Ear, nose and throat","slug":"ear-nose-throat"},{"id":"164e61aa-02a9-5edf-9943-5d891add3a7f","name":"Respiratory","slug":"respiratory"}],"chapters":[{"id":"147ea703-8a02-5151-abf9-289eb232d7f7","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"b4d7d104-fefd-5285-8bf6-a20db31a3a6c","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"9b0196f5-c62f-557e-8c0b-8d5cdc4726b8","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"770a8563-687d-5b41-9629-8cdcd49a750a","slug":"changes","fullItemName":"Changes"},{"id":"10a53caf-873e-57a4-880d-aefdd5a5fb65","slug":"update","fullItemName":"Update"}]},{"id":"bf5dbb8f-554f-56b2-b8ce-62573dd2d938","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"7d9ae47b-5ea9-557f-b53a-5bb9f9b69fcb","slug":"goals","fullItemName":"Goals"},{"id":"a5f272bf-bd65-5548-a253-2eece07472f4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b1168d32-0a16-5a45-844c-2f9e792cfccc","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"41533497-a783-5f26-98e4-554a82823d80","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"34edf552-026f-5c4d-b4ae-95034786ca88","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ba739830-6b73-555a-9c5f-3bf3e5ec3743","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0b7a2081-6723-53ae-9566-0481028ad175","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"467402a7-bf22-5f5b-8ad9-090c0b1b6be5","slug":"definition","fullItemName":"Definition"},{"id":"93d4df12-d240-53a9-bbc6-ad12f8363460","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0128d0fb-1a94-57dd-b210-2b011720efa2","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"0fa5d183-650e-5e12-a927-5e0bcff458bd","slug":"prognosis-complications","fullItemName":"Prognosis and complications"}]},{"id":"90baebc8-47bc-5144-a5ac-07ace34fe1d7","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"b1189f4d-058a-54f6-83c8-43ed93b0d1ab","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"6c26580b-53cc-5db0-838c-71e5841fe898","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"efe34746-d360-5ce2-bdc6-4aab25a98130","slug":"management","fullItemName":"Management","subChapters":[{"id":"3020718f-b53d-5af1-89e6-5a92a4c59075","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"86c15ba0-c5cc-5a85-8d4c-490305d1540f","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"76c755b1-a126-5291-8ae0-44276cfd3747","slug":"corticosteroids","fullItemName":"Corticosteroids"},{"id":"742b7beb-da22-597a-9bf5-35f9a3b8ff50","slug":"paracetamol-ibuprofen","fullItemName":"Paracetamol and ibuprofen"}]},{"id":"7ea6cbf9-fc01-56dd-8c9d-9b9cc1a69282","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"c93aeb25-1189-5e59-bec3-5210121ed220","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"f0d23dbb-0a01-5d60-9e6f-17bbf65083b3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"be9ee413-fa04-55ba-88df-d9606ca98a64","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d2337c68-6aec-522d-a1c5-329947299478","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"982ad0fa-2b63-5ea4-b6a3-200dca208aaa","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"86f92b32-a806-57d4-a00e-be2a234bfdee","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7b0c8a60-9bbe-5830-8e82-d9e6b1567c0b","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"ce03d247-afbe-5290-832f-8f95361dd16e"}},"staticQueryHashes":["3666801979"]}